Diseases & Disorders
(G80)
IRS Verified
DX Registered
EHE FOUNDATION
CharityAI™ Score
Not yet evaluated
Mission Statement
To find treatments and a cure for the rare cancer, Epithelioid Hemangioendothelioma (EHE), by advancing research and driving collaboration among patients, researchers, and clinicians.
Financial Overview — FY 2023
$415K
Total Revenue
$562K
Total Expenses
$1.7M
Net Assets
2
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
86.3%
Fundraising Efficiency
0.0%
Operating Reserve
36.82x
Liability-to-Asset
9.3%
Revenue Diversification
86.7%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $415K | $562K | $1.7M | 86.3% | 2 |
| 2022 | $894K | $942K | N/A | — | 0 |
| 2021 | $1.6M | $800K | N/A | — | 0 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.